CVS Health Corp vs Trump Media and Technology Group Corp — how do they compare? CVS Health Corp trades at $93.55 (market cap $119.58B), while Trump Media and Technology Group Corp trades at $8.32 (market cap $2.48B). The key difference: CVS Health Corp is far larger — about 48.2× Trump Media and Technology Group Corp's market cap, and CVS Health Corp pays a 2.84% dividend while Trump Media and Technology Group Corp pays none. Which is the better fit depends on your goals.
| CVS | DJT | |
|---|---|---|
Market Cap | $119.58B | $2.48B |
Sector | Health | Media |
52-Week High | $110.60 | $18.50 |
52-Week Low | $65.51 | $7.06 |
Enterprise Value | $181.93B | $2.54B |
Dividend Yield | 2.84% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $94.70, down 1.01% with strong technical support at $93-$91 levels. The company reported robust Q2 2026 earnings of $2.58 per share, beating estimates by 38%, while raising full-year guidance. Revenue growth accelerated to 7.3% year-over-year, driven by Aetna's recovery and retail strength. Analyst consensus remains overwhelmingly bullish with 84% buy ratings and a $115.90 price target representing 22% upside potential.
CVS presents compelling value with a 0.29 P/S ratio and positive earnings momentum, though net margins remain thin at 1.18%. Key risks include 2027 PBM pressure and healthcare regulatory changes. The stock's current technical weakness near support levels offers potential entry point for long-term investors seeking exposure to integrated healthcare services.
DJT stock trades at $8.38, down 10.81% in the last 24 hours, reflecting a bearish technical signal. The company reported Q2 2026 revenue of $1.67 million, up 89% year-over-year, but net losses widened to $238.1 million due to digital asset declines. The price-to-sales ratio of 547.62 indicates an extremely high valuation relative to minimal revenue, while negative profitability metrics and substantial cash burn persist.
The outlook remains highly speculative with significant risks from unsustainable losses and volatile digital asset holdings. Investment appeal is limited to high-risk tolerance given the lack of profitability and bearish analyst sentiment. Key catalysts include future revenue growth from new products like the Truth API, but current fundamentals do not support the valuation.
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Trump Media & Technology Group is a media firm rooted in social media and digital streaming. Its flagship product, Truth Social, provides a platform focused on free speech and open conversation.
Read more on DJT →